To all the researchers, and to those who are fighting the pandemic, our biggest Thanks. 2020 has changed the world, has revolutionized our lifestyle, and will leave us with historical changes. Let's think about writing a new story together.
A recent international partnership between researchers from Europe, USA, UK and Russia has investigated the effects of the pandemic mitigation strategies. Community and home care are the only viable strategies that could achieve the goal of pandemic mitigation
The e-cigarette aerosol foster the transmission of the SARS-CoV-2 virus? According to the research, vaping add 1% risk to the already existing risks from breathing indoor
What are the best practises the tobacco industry should follow to achieve a sustainable change through the innovation and regulation? This was the question that this year’s Global Tobacco and Nicotine Forum, GTFN 2020, focused on
In the past few days, seroepidemiological tests on citizens have been performed to assess the impact of smoking on the Covid-19 infections on the most vulnerable part of the population. The subjects of the study were selected according to a multi-layered probabilistic sampling plan by gender and age on citizens from 5 to over 80 years old. Among them, the employees of the Oasi of Troina, many of whom were tested positive to the Covid-19 infection.
An article published in the Lancet triggers the reaction of the scientific community that supports the tobacco harm reaction policies.
Talking about tobacco harm reduction means embracing a plurality of behaviors, choices and products that can be confusing. We have deepened the subject with Dr. Renée O’Leary, author of the paper and COEHAR researcher
The article highlights why harm reduction is important, what are the ways to achieve harm reduction, particularly the use of snus, heated tobacco products and e-cigarettes and what are the barriers to use of such alternatives. This article is not a systematic or narrative review; it is an overview of recent studies on these products or devices. Industry conducted or funded studies were excluded from the review.
Toxicological testing, population studies, clinical trials and randomized controlled trials demonstrate the potential reductions in exposures for smokers. Unfortunately, socio-cultural and economics barriers, such as heavy taxation, misperceptions about nicotine and unsubstantiated fears of youth addiction, prevent low risk products to become accessible to all and a good choice for those who want to quit smoking.
The findings from a survey conducted by COEHAR researchers on almost 2000 participants showed a slight decrease in the consumption of cigarettes during the lockdown period and an increase in the purchase of products such as cigarettes and e-liquid
We will send you direct emails, without intermediary services, you can withdraw any time.
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.